Food News and Research

RSS

Æterna Zentaris announces 2009 financial and operating results

Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today reported financial and operating results as at and for the fourth quarter and the full year ended December 31, 2009.

24 Mar 2010

New ‘Revitalizing Q10 Eye Roller Gel’ for men

NIVEA For MEN formally announced the launch of the brand’s new Revitalizing Q10 Eye Roller Gel today, a men’s eye care product engineered to minimize the look of fine lines and reduce the appearance of dark circles and puffiness underneath the eyes.

24 Mar 2010

InvestorSoup.com announces investment report featuring Oncothyreon

InvestorSoup.com announces an investment report featuring Oncothyreon Inc. (Nasdaq:ONTY). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

24 Mar 2010

Policymakers should determine risk-reduction initiatives to improve health systems, says new report

Tackling the increasing rates of cardiovascular disease in developing nations will require input from multiple partners, including the business community and international companies as well as global health and development agencies and the governments of these countries, says a new report from the Institute of Medicine.

24 Mar 2010

Sec. Clinton highlights water as diplomatic, development opportunity for U.S.

Marking World Water Day in a speech Monday, Secretary of State Hillary Rodham Clinton said tackling the world's water problems "represents one of the great diplomatic and development opportunities of our time," Inter Press Service reports. "It's not every day you find an issue where effective diplomacy and development will allow you to save millions of lives, feed the hungry, empower women, advance our national security interests, protect the environment, and demonstrate to billions of people that the United States cares," she said.

24 Mar 2010

First Edition: March 24, 2010

Today's headlines note the celebrations surrounding President Obama's signature of the Senate's health reform bill -- making it the law of the land -- and the strategies being developed by health overhaul opponents to block progress with an accompanying "fix it" bill.

24 Mar 2010

Consumers choose indulgent food items while shopping for others

Feel like Mom is pushing dessert? According to a new study in the Journal of Consumer Research, consumers choose foods that are less healthy when they are purchasing for others.

24 Mar 2010

AHF to protest against Merck's pricing of Isentress

AIDS Healthcare Foundation will host a protest Wednesday morning, March 24th at 10:30am targeting Merck and Co. Pharmaceuticals over the pricing and policies for its key HIV/AIDS drug, Isentress, one of the most expensive first-line AIDS treatment in the US, during the Barclays Capital Global Healthcare Conference.

24 Mar 2010

FDA recommends clinicians temporarily suspend use of Rotarix vaccine

The agency recently became aware that an independent U.S. academic research team, using a novel technique, has found DNA from porcine circovirus 1 (PCV1) in Rotarix, which is manufactured by GlaxoSmithKline. PCV1 is not known to cause illness in humans or other animals. In addition, Rotarix has been studied extensively, before and after approval, and found to have an excellent safety record.

24 Mar 2010

ACS webinar on chemistry for food safety

Scheduled for Thursday, April 1, 2 - 3 p.m. Eastern Time, the free webinar will feature Walter Hammack with the Florida Department of Agriculture, as he discusses the various chromatographic tools, methods and regulations for food safety. His topic: "How Chemistry is Keeping Your Food Safe -Application of Ultra High Pressure Liquid Chromatography (UHPLC) in a Food Safety Laboratory."

24 Mar 2010

New study shows leptin treatment may help reduce type 1 diabetes

Using leptin alone in place of standard insulin therapy shows promise in abating symptoms of type 1 diabetes, UT Southwestern Medical Center researchers report.

24 Mar 2010

Lap band surgery acceptable only for morbidly obese adolescents over 15

Lap band surgery is a procedure that involves placing a ring around the stomach and thus restricting it. It is a controversial procedure undertaken in obese patients to decrease food absorption.

24 Mar 2010

Farmers, aid groups call attention to drought, food shortages in West Africa

A coalition of farmers from West Africa's Sahel region, known as Billital Maroobe, wrote an open letter to regional leaders Monday, appealing for help with drought and famine conditions that are affecting people and livestock, Agence France-Presse/IC Publications reports.

24 Mar 2010

Merck Serono, EMD Serono suspend global clinical development program for Stimuvax temporarily

Oncothyreon Inc. today announced that Merck Serono, a division of Merck KGaA of Darmstadt, Germany, and its U.S. affiliate, EMD Serono, Inc., have temporarily suspended the worldwide clinical development program for Stimuvax(R) (BLP25 liposomal vaccine). The suspension is the result of a suspected unexpected serious adverse reaction in a patient with multiple myeloma participating in an exploratory clinical trial.

23 Mar 2010

FDA approves OrSense's NBM-200MP non-invasive oximetry and low signal oximetry sensor

OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, announced today it has received U.S. Food and Drug Administration (FDA) approval for NBM-200MP, a non-invasive oximetry and low signal oximetry sensor.

23 Mar 2010

Mach One completes “Definitive Agreement” for merger and acquisition of White Hat Brands

Mach One Corporation, a global wellness solutions company, today announced the completion of a “Definitive Agreement” for the terms and conditions for the merger and acquisition of White Hat Brands, LLC, producers of a variety of all natural, multi-vitamin-fortified juice beverages for children under the brand name Dog On It!™.

23 Mar 2010

EMA validates InterMune's pirfenidone MAA for IPF

InterMune, Inc. today announced that the company's Marketing Authorization Application (MAA), submitted on March 2 seeking approval of pirfenidone for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, was validated by the European Medicines Agency (EMA). Validation of the MAA by the EMA indicates that the application is complete and that the review process will begin on March 24. The proposed trade name for pirfenidone in both the United States and Europe is Esbriet®.

23 Mar 2010

AOAC Research Institute validates MicroSEQ Salmonella spp. Detection Kit

Life Technologies Corporation today announced that its Applied Biosystems MicroSEQ® Salmonella spp. Detection Kit has been validated by the AOAC Research Institute for detection of the bacteria Salmonella.

23 Mar 2010

Clinical Data completes NDA submission for vilazodone

Clinical Data, Inc., today announced that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for vilazodone for the treatment of major depressive disorder (MDD). Vilazodone is a dual-acting potent and selective serotonin reuptake inhibitor and a 5-HT1A receptor partial agonist. The Company expects that the NDA submission, if accepted, will be subject to a standard review.

23 Mar 2010

SAMHSA study shows how psychiatric drugs prescribed for medical conditions

A new study sponsored by the Substance Abuse and Mental Health Services Administration outlines the conditions that physicians around the country reported treating with psychiatric drugs such as antipsychotics, antidepressants, and anti-anxiety drugs.

23 Mar 2010